The molestation of shareholders continues. Lock up Gonzalez and Larson with Jared Fogel! Does NAVB get down to 1.34 today? Does Gonzalez give a damn? Hell, I think Navidea should wait until 2089 to launch the MT spinoff. By stating in the 10Q that the spinoff won't happen until Q1 2017 AT THE EARLIEST, they destroyed what little credibility they had left.
The lower the pps goes, the less Brent Larson gets on 12/1 when he sells another 12,500 shares. Hell, by then we could be at .64 and sliding lower.
2016 will be terrible for NAVB stock and the joke of a company known as Navidea. The company has wasted unimaginable millions on 5001 and 4694 and shareholders have suffered as a result. Perhaps the most telling reality here is that NO INSIDERS ARE BUYING, EVEN AT 1.50!
because the pps was rising strong and steady and things looked so great for the future of NAVB. Well, he was absolutely right. There was no pace car then and there sure as hell is no pace car in sight now for at least a year. In fact, Manocept goes no where in 2016 and we have to wait until 2017 for the spinoff according to the 10Q.
The 3.00 price target from the company in the 10Q is nonsense, as are ALL projections from the morons in Dublin.
Damn, I wish I bought all I could at 2.49!
MORE free SHARES to LARSON now SO he CAN SELL THEM ALL!
and the sooner the better. This nonsense needs to stop. There was no good reason to list NAVB on the TASE EXCEPT TO FLEECE MORE INVESTORS.
1.54 next week?
Even $4 million is not too great for 3 years after approval. But will it be $3 million or more tomorrow? It damn well better be, or Brent Larson will be lucky to get 1.00 per share on 12/1/15 when he sells another 12,500 shares. After all, his Public Assistance checks and Food Stamps only go so far.
Right andrwlp! NAVB doesn't need revenue right away to clean up their abominable quarterly reports. Waiting another year or longer for European revenue is just great. YOU are nonsense.
if you dare. Only headed lower, as the dream team will be proving itself to be as inept as Pykett and Tulip the tool.
This garbage is headed further down in 2 weeks. Thank your boy Gonzalez!
The revenue consensus seems to be somewhere between $2.9 million and $3.2 million. I'll be the first to say that while this range would be a huge improvement over Q2 and $1.98 million dollars, the market seems to be ignoring and abandoning NAVB just like Brent Larson selling out his NAVB position every 1st of the month. Oh, how sweet it would be to see NAVB at 0.50 on 11/2 just so Brent gets hit like the rest of us. But mark my words, the Q3 will not be enough to bring NAVB back to 2.00 - even if revenue is above $3.2 million. The relentless shorts are back and Larson is laughing at all NAVB longs again. Wonderful!
If Gonzalez can find the time to provide a real MT update of substance, THAT could mean something...but I know better.
1.84 by the end of the day?
1.67 by the end of the week?
I wish I owned 1,000,000,000,000,000,000,000,000,000,000,000,000 more shares!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
$3-$4 in how many years or decades? Other than the TASE listing, Navidea has done and said nothing to justify the current 2.17 stock price. The buyers are gone or hiding for now. And I'm starting to think that NAVB shareholders will only get a minimal share of the spinoff shares of MT whenever the hell the company decides to reveal just how much they want to stick it to shareholders AGAIN.
And does anyone expect Q3 earnings to be even acceptable? The shorts act as if a treat of revenues under $2 million is coming soon to a theater near you.
How nice it would be if the company provided some real Manocept progress, a 4694 partnership, or strong Lymphoseek sales. Q3 should be great. If not, say bye bye to a 2.00+ share price. And by great I mean $3 million OR MORE.
I'll take it over being down .14 again. Watson needs to get creative. Layoffs might help. Let's go. Investors are a waitin!
The shorts have lost their grip. It's stunning to think about all the control they had when NAVB traded all day long at 1.65 X 1.66 and it looked like 1.67 would never come. Those days are behind us.
1.22? Very unlikely. Even in general market weakness, NAVB outperforms!